24小時查詢服務熱線
香港網頁集團
  • 公司概覽 
    • 概覽 
    • 客戶群組 
    • 職位空缺 
  • 服務範圍 
    • 網頁設計 
    • 網絡行銷 
      • SEO搜尋引擎優化 
      • SEM搜尋引擎行銷 
      • 社交網絡推廣策略及推廣 
      • EDM 電郵宣傳策略及設計 
      • 部落格/博客/討論區行銷方案 
    • 網上推廣 
    • 人才外判計劃 
  • 優惠推介 
    • SE0上頭版推廣 
    • SEO教學課程 
  • 政府資助 
    • BUD專項基金(BUD Fund) 
    • EMF中小企業市場推廣基金 
    • TVP科技券計劃 
  • 作品展示 
  • 最新資訊 
    • 網頁設計 
    • 網上推廣 
    • APP開發 
  • 聯絡我們 
  • sitemap 
Home » Yaz, Yasmin Blood Clot Lawsuits Being Settled
  • 近期文章

    • 【社群行銷策略】投放廣告後會降低粉絲專頁的自主觸及率嗎?
    • 網頁設計技巧之12種讓Banner設計更具吸引力的方法!
    • 網站SEO基礎知識:什麼時候做網站SEO優化最好?只要產品有市場都可做SEO
    • UI設計技巧:如何巧妙地運用配色方案來創建不同調性的介面
    • SEO優化基礎知識:為什麼網站速度優化如此重要?網站速度該如何優化
  • 網上推廣

    • 【社群行銷策略】投放廣告後會降低粉絲專頁的自主觸及率嗎?
    • 網站SEO基礎知識:什麼時候做網站SEO優化最好?只要產品有市場都可做SEO
    • SEO優化基礎知識:為什麼網站速度優化如此重要?網站速度該如何優化
    • 如何擬定多語言網站的SEO優化策略?抓緊機遇,開拓更多國際市場!
    • 經營網站不可或缺的功能:如何透過站內搜尋改善網站SEO優化策略
  • 網頁設計

    • 網頁設計技巧之12種讓Banner設計更具吸引力的方法!
    • UI設計技巧:如何巧妙地運用配色方案來創建不同調性的介面
    • UI設計流行趨勢:Get好這四款近期非常流行的色彩趨勢!
    • 【優秀APP設計案例分析】如何設計出符合用戶喜好的旅遊類APP
    • 【UI設計案例分析】韓國UI設計好在哪?哪些地方值得我們學習
  • APP開發

    • 如何提高UI設計的精緻度?掌握這五個UI設計技巧
    • APP設計技巧:掌握這些APP設計細節,讓你的APP變得更加精緻
    • 【案例分析】韓國UI設計特點 提升作品的質感和設計感
    • APP設計新知:左文右圖和右文左圖的差異在哪裡
      APP設計新知:左文右圖和右文左圖的差異在哪裡
    • UI設計教程:關於APP頂部欄的UI設計規則和使用方式
      UI設計教程:關於APP頂部欄的UI設計規則和使用方式

Yaz, Yasmin Blood Clot Lawsuits Being Settled

分類: 網上推廣 Tags: Being, Blood, Clot, Lawsuits, Settled, Yasmin 日期: 2012-11-26

San Diego, CA (PRWEB) November 21, 2012

http://www.resource4thepeople.com/defectivedrugs/yasmin.html

Consumer News Weekly reports that there is encouraging legal news for women who have suffered blood-clotting, deep vein thrombosis or pulmonary embolisms because of their use of the popular birth control pills Yaz and Yasmin.

Bayer Pharmaceuticals, the giant German company that has sold billions of the oral contraceptives recently reported that it has paid out about $ 750 million to settle nearly 3,500 of the Yaz and Yasmin lawsuits that are part of a massive multi-district litigation in federal court.

The figures are contained in the companys third-quarter financial report to stockholders which recently was made public, detailing the substantial progress that has been made in settling these cases and the enormous amount of money being paid out to victims of Yaz and Yasmin side effects.

Consumer News Weekly notes that even while Bayer reported a surge in earnings during the quarter, the company is reporting that the amount of legal costs related to Yaz and Yasmin legal expenses is climbing significantly.

Many of these Yaz and Yasmin cases are being coordinated before a federal judge who is coordinating pre-trial evidence-gathering and legal filings (Southern District of Illinois.(MDL No. 2100, Southern District Illinois).

A review of the court docket in this multi-district litigation shows that the judge has not issued any order barring additional Yaz and Yasmin lawsuits being filed because the legal time limits have not expired for many women who may have suffered blood clots, deep vein thrombosis or pulmonary embolisms.

Consumer News Weekly provides links to Yaz and Yasmin lawyers who are offering free consultations for women who have suffered these side effects and are seeking experienced, aggressive Yaz and Yasmin attorneys. As with most legal cases, there may be legal deadlines for filing such a lawsuit so it is recommended that you contact us as soon as possible to preserve all of your legal options.

In a July 31, 2012 report, Bloomberg News reported that Bayer is preparing itself for massive payouts in legal costs associated with Yaz and Yasmin lawsuits:

Bayer also more than doubled its reserve for Yaz cases, setting aside 496 million euros ($ 610.5 million), the company said. The drugmaker set aside a total of about 200 million euros in 2010 and 2011, according to securities filings. We believe we have made appropriate provisions for most of the cases we consider to be worthy of settlement with these accounting measures, Bayer officials said in an e-mailed statement.

Bloomberg quoted drug-industry analysts, such as JPMorgan Chase & Co.s Richard Vosser, as saying that they estimate that Bayer may have to pay more than 2 billion euros to resolve all the cases over the pills.

Yaz and Yasmin have long been among the best-selling oral contraceptives in the marketplace since they were first approved by the Food and Drug Administration, Yaz, in 2001 and Yasmin in 2006.

The pills both contain drospirenone, a synthetic form of progestin, which, according to claims common to the allegations contained in the Illinois federal litigation, increases the level of potassium in the blood and can cause heart rhythm problems leading to creation of blood clots.

According to an FDA health advisory issued April, 10, 2012, Bayer was directed to place new labeling on Yaz and Yasmin reporting that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins.

The FDA also issued, in bold face type the following recommendations in regards to Yaz, Yasmin and other drospirenone-containing contraceptives:

Women should talk to their healthcare professional about their risk for blood clots before deciding which birth control method to use.

Healthcare professionals should consider the risks and benefits of drospirenone-containing birth control pills and a womans risk for developing a blood clot before prescribing these drugs.

In addition to the FDA concerns about the safety of Yaz and Yasmin, the national, non-profit consumer organization Public Citizens medical research staff cited the same blood-clotting risks and warned consumers not to use the contraceptives:

We reviewed YASMIN in the April 2002 Worst Pills, Best Pills News and listed it as a Do Not Use drug for two reasons:

1) Drospirenone causes elevated blood levels of potassium that may cause serious heart and other health problems such as a change in blood acid balance and muscle weakness; and:

2) There is no evidence that YASMIN is superior in any way to older contraceptive products. For the same reasons, we subsequently listed YAZ as a Do Not Use drug.

Drospirenone is a close chemical cousin of spironolactone (ALDACTONE), a diuretic or water pill that causes the body to retain potassium. A 3-milligram dose of drospirenone, the amount in a daily contraceptive pill, is equivalent to 25 milligrams of spironolactone.

The problems that these risks can cause were outlined in some of the most recent Yaz and Yasmin lawsuits that have been filed by women who have suffered these dangerous side effects.

For instance, two months ago, five women filed Yaz and Yasmin lawsuits (3:2012cv11374) in Illinois Southern District Court in which they claimed to have suffered devastating health problems, including deep vein thrombosis and pulmonary embolisms because they used the birth control pills.

In this case, Jennifer Benefield, Melissa Wray, Cheryl Campos, Cheryl Hill and Rosemary Hampton filed allegations mirroring the risks cited by the FDA because, they said, they took the pills but were unaware of the dangerous side effects.

One of the victims, Wray, was forced to have her gall bladder removed in 2009, according to the allegations.

Consumer News Weekly urges any woman who has taken Yaz or Yasmin and suffered health complications to immediately seek advice from qualified health care professionals.

If these complications were caused by the use of the pills, Consumer News Weekly also recommends that Yaz or Yasmin victims contact our team of attorneys for a free consultation about the legal options that may be available to them.

As has been noted above, Bayer is in the process of settling many of these Yaz and Yasmin lawsuits and has set aside substantial amounts of funds for the legal costs the company will have to pay as a result of these blood-clotting side effects.

The legal process includes out-of-court settlements in which defendants such as Bayer may choose to settle cases and compensate victims rather than go to trial and risk jury awards that may be higher.

http://www.resource4thepeople.com/defectivedrugs/yasmin.html


Sources:

http://www.stockholders-newsletter-q3-2012.bayer.com/en/bayer-stockholders-newsletter-3q-2012.pdfx

http://www.bloomberg.com/news/2012-07-31/bayer-s-yasmin-lawsuit-settlements-rise-to-402-6-million.html

In re: Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Product Liability Litigation, 09-md-02100, U.S. District Court, Southern District of Illinois (East St. Louis)

http://www.fda.gov/Drugs/DrugSafety/ucm299305.htm

http://www.worstpills.org/member/newsletter.cfm?n_id=743

U.S. District Court, Southern District of Illinois 3:2012cv11374







Share This Post!

Subscribe to our RSS feed. Tweet this! StumbleUpon Reddit Digg This! Bookmark on Delicious Share on Facebook
訂閱電子報 公司最新資訊 Inspirr咨詢熱線
公司最新資訊
Inspirr咨詢熱線
公司最新資訊
Inspirr咨詢熱線
    • 網頁設計
    • 平面設計
    • 網上推廣
    • 程式開發
    Inspirr網頁設計香港
    公司資訊
    概覽
    職位空缺
    服務範圍
    網站設計流程
    SEO網站優化
    手機程式開發
    平面設計
    作品案例
    網頁設計案例
    手機程式案例
    多媒體設計案例
    平面商業設計案例
    聯繫我們
    • inspirr Facebook
    • inspirr vimeo
    • inspirr blog
    • 雅虎認證官網
    • 新浪微博認證

    Inspirr網頁設計公司專業設計網站

    網頁設計、網上商店、編寫程序、網上顧問、網上廣告、網上行銷等。我們擁有優秀專業的團隊,獨特的網頁設計功能,Web Design等技術,秉持網上商店品質、創新、服務的經營理念,集合設計、科技及網上推廣的元素。

    inspirr地址

    香港上環德輔道中248號東協商業大廈6樓601室

    Inspirr聯繫電話

    (852) 3749 9734

    Inspirr郵箱

    Copyright @ 2022 Inspirr Creation. All rights reserved.

    友情鏈接: 香港網頁設計 公司網站管理